Home > News > Nanoparticles May Detect Alzheimer's, Reversal Of Memory Loss
September 18th, 2003
Nanoparticles May Detect Alzheimer's, Reversal Of Memory Loss
Researchers have discovered for the first time in humans the presence of neurotoxic peptide assemblies that may be responsible for the memory loss found in individuals suffering from Alzheimer's disease (AD). The next step is to develop clinical diagnostics -- using nanoparticles -- to detect the amyloid beta-derived diffusible ligands (ADDLs), and effective drugs that prevent the onset of AD, delay its progression, and potentially restore cognitive function in patients with memory-related disorders, as reported in NanoBiotech News.
Countdown to zero: New 'zero-dimensional' carbon nanotube may lead to superthin electronics and synt December 11th, 2013
Nanobotmodels medical animation studio presents education video about prion disease December 11th, 2013
ASTM International Nanotechnology Committee Approves Airborne Nanoparticle Measurement Standard December 10th, 2013
Recycled Plastic Proves Effective in Killing Drug-Resistant Fungi: IBN and IBM discover new medical application for converted PET bottles December 9th, 2013